(FUL) H Fuller - Ratings and Ratios
Adhesives, Sealants, Coatings, Chemical Products, Tapes
FUL EPS (Earnings per Share)
FUL Revenue
Description: FUL H Fuller
H.B. Fuller Company is a leading global manufacturer of adhesives, sealants, and specialty chemicals, operating through three main segments: Hygiene, Health and Consumable Adhesives, Engineering Adhesives, and Construction Adhesives. The companys diverse product portfolio caters to various industries, including packaging, nonwoven, healthcare, automotive, electronics, and construction.
The companys business segments demonstrate a strong presence in the global market, with Hygiene, Health and Consumable Adhesives serving the packaging and hygiene industries, Engineering Adhesives targeting high-performance applications in durable assembly and transportation, and Construction Adhesives providing products for tile setting, roofing, and insulation. H.B. Fuller Companys products are sold directly to customers, as well as through distributors and retailers across multiple regions, including North America, Latin America, Europe, and Asia Pacific.
To evaluate the companys performance, key performance indicators (KPIs) such as revenue growth, gross margin ratio, and operating cash flow margin can be analyzed. A review of the companys financials reveals that its revenue has been steadily increasing, driven by a combination of organic growth and strategic acquisitions. The gross margin ratio has remained relatively stable, indicating the companys ability to maintain its pricing power and manage raw material costs. Additionally, the operating cash flow margin has been improving, suggesting effective cost management and operational efficiency.
Further analysis of H.B. Fuller Companys financials and industry trends reveals opportunities for growth in emerging markets, driven by increasing demand for specialty adhesives and sealants. The companys commitment to innovation and R&D has enabled it to stay ahead of the competition, with a strong pipeline of new products and technologies. As a Trading Analyst, it is essential to monitor the companys progress in executing its growth strategy and adjusting to changing market conditions.
FUL Stock Overview
| Market Cap in USD | 3,202m |
| Sub-Industry | Specialty Chemicals |
| IPO / Inception | 1990-03-26 |
FUL Stock Ratings
| Growth Rating | -11.7% |
| Fundamental | 48.5% |
| Dividend Rating | 58.6% |
| Return 12m vs S&P 500 | -37.3% |
| Analyst Rating | 3.50 of 5 |
FUL Dividends
| Dividend Yield 12m | 1.51% |
| Yield on Cost 5y | 2.02% |
| Annual Growth 5y | 6.13% |
| Payout Consistency | 97.0% |
| Payout Ratio | 24.3% |
FUL Growth Ratios
| Growth Correlation 3m | 38% |
| Growth Correlation 12m | -71.6% |
| Growth Correlation 5y | 35% |
| CAGR 5y | 6.14% |
| CAGR/Max DD 5y | 0.14 |
| Sharpe Ratio 12m | -2.08 |
| Alpha | -39.67 |
| Beta | 0.763 |
| Volatility | 28.67% |
| Current Volume | 281.4k |
| Average Volume 20d | 320.2k |
| Stop Loss | 59.2 (-3%) |
| Signal | 0.70 |
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (103.1m TTM) > 0 and > 6% of Revenue (6% = 211.7m TTM) |
| FCFTA 0.02 (>2.0%) and ΔFCFTA -3.24pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 17.08% (prev 17.19%; Δ -0.11pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.05 (>3.0%) and CFO 231.2m > Net Income 103.1m (YES >=105%, WARN >=100%) |
| Net Debt (2.02b) to EBITDA (476.8m) ratio: 4.23 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.87 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (55.0m) change vs 12m ago -2.97% (target <= -2.0% for YES) |
| Gross Margin 30.05% (prev 30.29%; Δ -0.24pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 70.20% (prev 71.78%; Δ -1.58pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.20 (EBITDA TTM 476.8m / Interest Expense TTM 135.8m) >= 6 (WARN >= 3) |
Altman Z'' 2.93
| (A) 0.12 = (Total Current Assets 1.29b - Total Current Liabilities 692.1m) / Total Assets 5.13b |
| (B) 0.38 = Retained Earnings (Balance) 1.95b / Total Assets 5.13b |
| (C) 0.06 = EBIT TTM 299.5m / Avg Total Assets 5.03b |
| (D) 0.49 = Book Value of Equity 1.60b / Total Liabilities 3.26b |
| Total Rating: 2.93 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 48.50
| 1. Piotroski 3.50pt = -1.50 |
| 2. FCF Yield 2.25% = 1.13 |
| 3. FCF Margin 3.33% = 0.83 |
| 4. Debt/Equity 1.13 = 1.90 |
| 5. Debt/Ebitda 4.43 = -2.50 |
| 6. ROIC - WACC -0.48% = -0.60 |
| 7. RoE 5.63% = 0.47 |
| 8. Rev. Trend -25.54% = -1.28 |
| 9. Rev. CAGR -1.69% = -0.28 |
| 10. EPS Trend -2.78% = -0.07 |
| 11. EPS CAGR 3.98% = 0.40 |
What is the price of FUL shares?
Over the past week, the price has changed by -1.86%, over one month by +4.61%, over three months by +9.51% and over the past year by -26.62%.
Is H Fuller a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of FUL is around 55.84 USD . This means that FUL is currently overvalued and has a potential downside of -8.53%.
Is FUL a buy, sell or hold?
- Strong Buy: 2
- Buy: 0
- Hold: 3
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the FUL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 66.2 | 8.4% |
| Analysts Target Price | 60.2 | -1.4% |
| ValueRay Target Price | 60.7 | -0.5% |
Last update: 2025-08-22 04:38
FUL Fundamental Data Overview
CCE Cash And Equivalents = 96.8m USD (last quarter)
P/E Trailing = 32.2446
P/E Forward = 12.0048
P/S = 0.9075
P/B = 1.7078
P/EG = 2.2309
Beta = 1.128
Revenue TTM = 3.53b USD
EBIT TTM = 299.5m USD
EBITDA TTM = 476.8m USD
Long Term Debt = 2.11b USD (from longTermDebt, last quarter)
Short Term Debt = unknown (0.0)
Debt = 2.11b USD (Calculated: Short Term 0.0 + Long Term 2.11b)
Net Debt = 2.02b USD (from netDebt column, last quarter)
Enterprise Value = 5.22b USD (3.20b + Debt 2.11b - CCE 96.8m)
Interest Coverage Ratio = 2.20 (Ebit TTM 299.5m / Interest Expense TTM 135.8m)
FCF Yield = 2.25% (FCF TTM 117.6m / Enterprise Value 5.22b)
FCF Margin = 3.33% (FCF TTM 117.6m / Revenue TTM 3.53b)
Net Margin = 2.92% (Net Income TTM 103.1m / Revenue TTM 3.53b)
Gross Margin = 30.05% ((Revenue TTM 3.53b - Cost of Revenue TTM 2.47b) / Revenue TTM)
Tobins Q-Ratio = 3.27 (Enterprise Value 5.22b / Book Value Of Equity 1.60b)
Interest Expense / Debt = 1.65% (Interest Expense 34.9m / Debt 2.11b)
Taxrate = 30.87% (from yearly Income Tax Expense: 56.4m / 182.7m)
NOPAT = 207.0m (EBIT 299.5m * (1 - 30.87%))
Current Ratio = 1.87 (Total Current Assets 1.29b / Total Current Liabilities 692.1m)
Debt / Equity = 1.13 (Debt 2.11b / last Quarter total Stockholder Equity 1.87b)
Debt / EBITDA = 4.43 (Net Debt 2.02b / EBITDA 476.8m)
Debt / FCF = 17.96 (Debt 2.11b / FCF TTM 117.6m)
Total Stockholder Equity = 1.83b (last 4 quarters mean)
RoA = 2.01% (Net Income 103.1m, Total Assets 5.13b )
RoE = 5.63% (Net Income TTM 103.1m / Total Stockholder Equity 1.83b)
RoCE = 7.60% (Ebit 299.5m / (Equity 1.83b + L.T.Debt 2.11b))
RoIC = 5.29% (NOPAT 207.0m / Invested Capital 3.91b)
WACC = 5.77% (E(3.20b)/V(5.31b) * Re(8.83%)) + (D(2.11b)/V(5.31b) * Rd(1.65%) * (1-Tc(0.31)))
Shares Correlation 5-Years: 0.0 | Cagr: -0.01%
Discount Rate = 8.83% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 75.43% ; FCFE base≈179.5m ; Y1≈179.1m ; Y5≈189.2m
Fair Price DCF = 53.80 (DCF Value 2.90b / Shares Outstanding 54.0m; 5y FCF grow -0.83% → 3.0% )
Revenue Correlation: -25.54 | Revenue CAGR: -1.69%
Rev Growth-of-Growth: 1.83
EPS Correlation: -2.78 | EPS CAGR: 3.98%
EPS Growth-of-Growth: -17.52
Additional Sources for FUL Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle